Guo-Qing Jiang

Clinical Medical College of Yangzhou University · Clinical Medical College, Yangzhou University

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

197

PubMed author-name match

Trials

Studies that name Guo-Qing Jiang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:51 UTC. Open this list on ClinicalTrials.gov

N/A
NCT07811700 · Effect of LSD on Lipid Profiles Within 1 Year Postoperatively in Cirrhosis Patients With Portal Hypertension Bleeding
Northern Jiangsu People's Hospital · completed · Lipid Profiles, Cirrhosis, Liver, Portal Hypertension · study chair
N/A
NCT07811687 · Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function
Northern Jiangsu People's Hospital · recruiting · Liver Cirrhosis, HCC - Hepatocellular Carcinoma, Hypersplenism · study chair
N/A
NCT07585786 · Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
Northern Jiangsu People's Hospital · not yet recruiting · Cirrhosis, Liver, Splenectomy; Status, Renal Function Abnormal · study chair
N/A
NCT07588334 · Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
Northern Jiangsu People's Hospital · not yet recruiting · Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension · study chair
N/A
NCT07588373 · Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
Northern Jiangsu People's Hospital · not yet recruiting · Cirrhosis, Splenectomy; Status, Hypersplenism · study chair
N/A
NCT07585773 · Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
Northern Jiangsu People's Hospital · not yet recruiting · Cirrhosis, Splenectomy; Status, Hypersplenism · study chair
N/A
NCT07462091 · Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
Northern Jiangsu People's Hospital · recruiting · Cirrhosis, Hypersplenism, Hypertension, Portal · principal investigator
N/A
NCT07205471 · Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Northern Jiangsu People's Hospital · recruiting · Cirrhoses, Liver, Splenectomy; Status, Partial · study chair
N/A
NCT07053605 · Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen
Northern Jiangsu People's Hospital · recruiting · Splenic Artery Aneurysm, Immune Function, Hemodynamics · study chair
N/A
NCT05433467 · CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
Northern Jiangsu People's Hospital · recruiting · Cirrhosis, Liver, Hepatocellular Carcinoma · study chair
N/A
NCT05338294 · The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients
Northern Jiangsu People's Hospital · recruiting · Cirrhosis, Liver, Splenectomy; Status · study chair
N/A
NCT05339269 · The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis Patients
Northern Jiangsu People's Hospital · completed · Cirrhosis, Liver, Splenectomy; Status · study chair
N/A
NCT05325437 · The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients
Northern Jiangsu People's Hospital · recruiting · Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension · study chair
N/A
NCT05325424 · The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients
Northern Jiangsu People's Hospital · recruiting · Cirrhosis, Liver, Splenectomy; Status · study chair
N/A
NCT05300516 · Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection
Northern Jiangsu People's Hospital · completed · Cirrhosis, Hypertension, Splenectomy · principal investigator
Ph4
NCT04645550 · Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
Northern Jiangsu People's Hospital · completed · Cirrhosis, Splenectomy; Status, Venous Thrombosis · study director
N/A
NCT03396796 · Modified Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal Disconnection
Yangzhou University · completed · Cirrhosis, Hypertension, Splenectomy · principal investigator
Ph4
NCT02247414 · Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
Yangzhou University · completed · Cirrhosis, Hypertension, Status;Splenectomy · study director
Ph4
NCT02238444 · Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
Yangzhou University · unknown · Cirrhosis, Hypertension, Venous Thrombosis · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:51 UTC. The ranking covers the 200 most relevant of 197 PubMed records, and a shared surname and initials can bring in a namesake. All 197 on PubMed

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study.
Ann Oncol · 2015
605 citations
RCR 17.5
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
N Engl J Med · 2019
495 citations
RCR 21.8
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.
J Clin Oncol · 2015
317 citations
RCR 9.2
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
JAMA Oncol · 2020
267 citations
RCR 11.0
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.
Nephrol Dial Transplant · 2017
170 citations
RCR 6.6
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.
Clin Pharmacol Ther · 2010
148 citations
RCR 4.0
Thoracoscopic Surgery Versus Thoracotomy for Lung Cancer: Short-Term Outcomes of a Randomized Trial.
Ann Thorac Surg · 2018
112 citations
RCR 5.1
Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke: The POST-TNK Randomized Clinical Trial.
JAMA · 2025
83 citations
RCR 27.3
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol · 2022
82 citations
RCR 4.3
Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer.
J Clin Oncol · 2003
78 citations
RCR 1.4